As an explanation for this greater variability, we hypothesize that LTEC patients are a rather heterogeneous group [3] in terms of factors such as the time of the infection control, CD4 count, and other unknown factors that may be related to the various mechanisms operating in these patients to achieve the control of viral replication and infection progression. This evidence concerns the gene CD4 and infection.